Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University
About this trial
This randomized controlled trial evaluates whether adding point-of-care intestinal ultrasound (IUS) to standard of care changes clinical management in patients with inflammatory bowel disease (IBD). Adult patients with Crohn's disease or ulcerative colitis undergoing colonoscopy for disease assessment are randomized 1:1 to standard of care plus IUS at every visit, or standard of care alone, and followed for 48 weeks. The primary outcome is the proportion of patients with a change in treatment.
Eligibility criteria
Qualifiers
Diagnosis of inflammatory bowel disease for more than 2 months
Age 18 years or older
Undergoing endoscopy at enrollment for assessment of disease severity
Disqualifiers
Pregnancy
Unstable underlying medical conditions
Inflammatory bowel disease limited to the distal rectum (within 10 cm of the anal verge) or perianal disease only
Biologic failure
Trial design
Treatments tested in this trial
- Intestinal ultrasound (IUS)
- Standard of care
Treatment groups
137 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov